Four-factor prothrombin complex concentrate is not inferior to andexanet alfa for the reversal or oral factor Xa inhibitors: An Eastern Association for the Surgery of Trauma multicenter study
- Jordan M. Estroff
- , Joseph Devlin
- , Lara Hoteit
- , Adnan Hassoune
- , Matthew D. Neal
- , Joshua B. Brown
- , Liling Lu
- , Shannon Kotch
- , Joshua P. Hazelton
- , Ashton B. Christian
- , Eric O. Yeates
- , Jeffry Nahmias
- , Lewis E. Jacobson
- , Jamie Williams
- , Kevin M. Schuster
- , Rick O'Connor
- , Gregory R. Semon
- , Angela D. Straughn
- , Daniel Cullinane
- , Tanya Egodage
Research output: Contribution to journal › Article › peer-review